Validation of a self-completed Dystonia Non-Motor Symptoms Questionnaire.


Journal

Annals of clinical and translational neurology
ISSN: 2328-9503
Titre abrégé: Ann Clin Transl Neurol
Pays: United States
ID NLM: 101623278

Informations de publication

Date de publication:
10 2019
Historique:
received: 13 08 2019
accepted: 19 08 2019
pubmed: 29 9 2019
medline: 8 9 2020
entrez: 28 9 2019
Statut: ppublish

Résumé

To develop and validate a novel 14-item self-completed questionnaire (in English and German) enquiring about the presence of non-motor symptoms (NMS) during the past month in patients with craniocervical dystonia in an international multicenter study. The Dystonia Non-Motor Symptoms Questionnaire (DNMSQuest) covers seven domains including sleep, autonomic symptoms, fatigue, emotional well-being, stigma, activities of daily living, sensory symptoms. The feasibility and clinimetric attributes were analyzed. Data from 194 patients with CD (65.6% female, mean age 58.96 ± 12.17 years, duration of disease 11.95 ± 9.40 years) and 102 age- and sex-matched healthy controls (66.7% female, mean age 55.67 ± 17.62 years) were collected from centres in Germany and the UK. The median total NMS score in CD patients was 5 (interquartile range 3-7), significantly higher than in healthy controls with 1 (interquartile range 0.75-2.25) (P < 0.001, Mann-Whitney U-test). Evidence for intercorrelation and convergent validity is shown by moderate to high correlations of total DNMSQuest score with motor symptom severity (TWSTRS: r The DNMSQuest, a patient self-completed questionnaire for NMS assessment in CD patients, appears robust, reproducible, and valid in clinical practice showing a tangible impact of NMS on quality of life in CD. As there is no specific, comprehensive, validated tool to assess the burden of NMS in dystonia, the DNMSQuest can bridge this gap and could easily be integrated into clinical practice.

Identifiants

pubmed: 31560179
doi: 10.1002/acn3.50900
pmc: PMC6801169
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2054-2065

Informations de copyright

© 2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association.

Références

Alzheimer Dis Assoc Disord. 2013 Jan-Mar;27(1):37-43
pubmed: 22193353
Neurol Genet. 2016 Apr 11;2(3):e69
pubmed: 27123488
Parkinsonism Relat Disord. 2016 Nov;32:48-53
pubmed: 27553512
J Neurol. 2002 Jul;249(7):842-6
pubmed: 12140667
Eur J Neurol. 2007 Oct;14(10):1129-37
pubmed: 17708754
Mov Disord. 2016 Apr;31(4):563-9
pubmed: 26971359
BMC Neurol. 2014 Apr 27;14:91
pubmed: 24767576
Parkinsonism Relat Disord. 2014 Apr;20(4):405-8
pubmed: 24486141
Parkinsonism Relat Disord. 2016 Sep;30:7-12
pubmed: 27321988
J Clin Epidemiol. 1993 Dec;46(12):1417-32
pubmed: 8263569
J Neurol. 2012 Aug;259(8):1639-47
pubmed: 22237822
Spine (Phila Pa 1976). 2000 Dec 15;25(24):3186-91
pubmed: 11124735
J Neurol Neurosurg Psychiatry. 2005 Jan;76(1):58-63
pubmed: 15607996
Mov Disord Clin Pract. 2015 Jun;2(2):135-141
pubmed: 27088112
Health Technol Assess. 2005 Mar;9(10):1-93, iii-iv
pubmed: 15774233
Tremor Other Hyperkinet Mov (N Y). 2013 Nov 04;3:null
pubmed: 24255801
Mov Disord. 2011 Jun;26(7):1206-17
pubmed: 21484874
Mov Disord. 2006 Jul;21(7):916-23
pubmed: 16547944
Mov Disord. 2011 Feb 15;26(3):399-406
pubmed: 21264941
J Neurol Neurosurg Psychiatry. 2002 May;72(5):608-14
pubmed: 11971047
Neurology. 1985 Jan;35(1):73-7
pubmed: 3966004
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Expert Rev Neurother. 2018 Jan;18(1):41-50
pubmed: 29090594
Neurology. 2010 Nov 9;75(19):1717-25
pubmed: 21060094
J Neurol. 2000 Oct;247(10):787-92
pubmed: 11127535
Mov Disord. 2002 Jul;17(4):838-41
pubmed: 12210891
Parkinsonism Relat Disord. 2015 Mar;21(3):287-91
pubmed: 25616694
J Neurol Neurosurg Psychiatry. 2004 May;75(5):749-53
pubmed: 15090572
J Neural Transm (Vienna). 2013 Mar;120(3):487-96
pubmed: 22899277
PLoS One. 2013;8(2):e57221
pubmed: 23468940
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
Mov Disord. 2013 Jun 15;28(7):863-73
pubmed: 23649720
Arq Neuropsiquiatr. 2014 Jun;72(6):405-10
pubmed: 24964104
Mov Disord. 2003 Mar;18(3):303-12
pubmed: 12621634
Mov Disord. 2013 Jun 15;28(7):874-83
pubmed: 23893443
Funct Neurol. 2007 Apr-Jun;22(2):95-100
pubmed: 17637212
Mov Disord. 2004 Sep;19(9):1054-9
pubmed: 15372595

Auteurs

Lisa Klingelhoefer (L)

Department of Neurology, Technical University Dresden, Dresden, Germany.

Kallol R Chaudhuri (KR)

National Parkinson Foundation International Centre of Excellence, Department of Neurology, King's College Hospital, London, United Kingdom.

Christoph Kamm (C)

Department of Neurology, University of Rostock, Rostock, Germany.
German Centre for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, Rostock, Germany.

Pablo Martinez-Martin (P)

National Centre of Epidemiology and CIBERNED, Carlos III Institute of Health, Madrid, Spain.

Kailash Bhatia (K)

Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London, United Kingdom.

Anna Sauerbier (A)

National Parkinson Foundation International Centre of Excellence, Department of Neurology, King's College Hospital, London, United Kingdom.

Maximilian Kaiser (M)

Department of Neurology, Technical University Dresden, Dresden, Germany.

Carmen Rodriguez-Blazquez (C)

National Centre of Epidemiology and CIBERNED, Carlos III Institute of Health, Madrid, Spain.

Bettina Balint (B)

Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology, London, United Kingdom.
Department of Neurology, University Hospital, Heidelberg, Germany.

Robert Untucht (R)

Department of Neurology, Technical University Dresden, Dresden, Germany.

Lynsey J Hall (LJ)

National Parkinson Foundation International Centre of Excellence, Department of Neurology, King's College Hospital, London, United Kingdom.

Lauritz Mildenstein (L)

Department of Neurology, University of Rostock, Rostock, Germany.

Miriam Wienecke (M)

Department of Neurology, Technical University Dresden, Dresden, Germany.

Davide Martino (D)

Department of Clinical Neurosciences, University of Calgary & Hotchkiss Brain Institute, Calgary, Canada.

Olaf Gregor (O)

Department of Neurology, Klinikum Chemnitz, Chemnitz, Germany.

Alexander Storch (A)

Department of Neurology, University of Rostock, Rostock, Germany.
German Centre for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, Rostock, Germany.

Heinz Reichmann (H)

Department of Neurology, Technical University Dresden, Dresden, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH